Investors give the thumbs-up to EntreMed's (ENMD +1.4%) decision today to name Ken K. Ren as...


Investors give the thumbs-up to EntreMed's (ENMD +1.4%) decision today to name Ken K. Ren as chief executive officer, after completing a one year stint as interim CEO. The company also names James Huang and Y. Alexander Wu as new members of the company's board of directors.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs